Opus Genetics Files 2024 10-K
Ticker: IRD · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1228627
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Opus Genetics filed its 2024 10-K, detailing financials and operations for the year ending Dec 31, 2024.
AI Summary
Opus Genetics, Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Ocuphire Pharma, Inc., is involved in pharmaceutical preparations. The filing details its financial position and business operations for the period.
Why It Matters
This 10-K filing provides a comprehensive overview of Opus Genetics' financial health and strategic direction for the fiscal year 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Opus Genetics faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K report.)
- 2025-03-31 — Filing Date (The date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- Opus Genetics, Inc. (company) — Filer of the 10-K
- Ocuphire Pharma, Inc. (company) — Former name of Opus Genetics, Inc.
- REXAHN PHARMACEUTICALS, INC. (company) — Previous former name of Opus Genetics, Inc.
- CORPORATE ROAD SHOW DOT COM INC (company) — Earlier former name of Opus Genetics, Inc.
- 2024-12-31 (date) — Fiscal year end date
- 2025-03-31 (date) — Filing date of the 10-K
FAQ
What was the primary business of Opus Genetics, Inc. during the fiscal year ending December 31, 2024?
The company is classified under the SIC code 2834, indicating its business is in Pharmaceutical Preparations.
When was the 10-K filing for the fiscal year 2024 submitted?
The 10-K filing was submitted on March 31, 2025.
What were the previous names of Opus Genetics, Inc.?
Opus Genetics, Inc. was formerly known as Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., and CORPORATE ROAD SHOW DOT COM INC.
In which state was Opus Genetics, Inc. incorporated?
Opus Genetics, Inc. was incorporated in Delaware (DE).
What is the business address of Opus Genetics, Inc.?
The business address is 8 DAVIS DRIVE, SUITE 220, DURHAM, NC 27709.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Opus Genetics, Inc. (IRD).